Showing 11-13 of 13 grants
| Title | Institution | Researcher | Program | Duration | Total Award Amount |
|---|---|---|---|---|---|
| Targeting type 1 Diabetes through Polyamines with DFMO | Trustees of Indiana University | Emily Sims | Cures | 01-October-2022 to 30-September-2026 | $3.693.701,00 |
| Preclinical evaluation of SERCA2 activators for pancreatic beta-cell protection in T1D | Neurodon LLC | Russell Dahl | Cures | 01-June-2022 to 31-May-2026 | $920.000,00 |
| Injectable Glucose-Responsive Hydrogels for Multi-Hormone Therapy | University of Notre Dame | Matthew Webber | Improving Lives | 01-March-2020 to 28-February-2026 | $750.000,00 |